Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Chad M. Robins currently holds 2,180,518 shares of Adaptive Biotechnologies Corp (ADPT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Chad M. Robins has been a net seller of ADPT stock. They have purchased $0 and sold $51.9M worth of shares.
Chad M. Robins's most recent insider trade was on Apr 8, 2026, when they sold 37,263 shares at $15.19 per share.
Chad M. Robins serves as Executive at Adaptive Biotechnologies Corp (ADPT). They have executed 193 insider transactions totaling $51.9M over their tenure at the company.
Chad M. Robins holds the position of Executive at Adaptive Biotechnologies Corp, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 7 years and currently hold a stake valued at $0.
Chad M. Robins has shown a selling trading pattern, with $0 in total purchases and $51.9M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Chad M. Robins was on Dec 1, 2025, when they sold $2.4M worth of ADPT shares. This transaction involved 124,998 shares at $18.94 per share.
Chad M. Robins currently owns 2,180,518 shares of Adaptive Biotechnologies Corp (ADPT), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Chad M. Robins's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Chad M. Robins has 193 Form 4 filings on record as an insider at Adaptive Biotechnologies Corp.
Set alerts for Chad M. Robins and 40,000+ other insiders.